Abstract

The present study aims to analyze the expression of long noncoding RNA (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) in human osteosarcoma (OS) cells and to investigate its role in OS-induced angiogenesis. MALAT1 expression in OS cells was significantly higher than in normal osteoblasts. The functional analysis indicated that MALAT1 appears to enhance OS-induced angiogenesis, in vitro and in vivo analyses, endothelial cell proliferation and migration, chick embryo angiogenesis assay, and zebrafish xenograft model. Mechanistically, silencing MALAT1 downregulated vascular endothelial growth factor A (VEGFA) expression and upregulated miR-150-5p expression in OS cells, and MALAT1-mediated angiogenic induction by VEGFA in OS microenvironment. Moreover, MALAT1 directly targeted miR-150-5p and miR-150-5p directly target VEGFA in OS. Overexpression of miR-150-5p downregulates VEGFA expression in OS. More notably, we showed that MALAT1 induced angiogenesis in OS microenvironment by upregulating the expression of VEGFA via targeting miR-150-5p. Overall, our findings suggest that MALAT1 promotes angiogenesis by regulating the miR-150-5p/VEGFA signaling in OS microenvironment. The findings of the molecular mechanisms of MALAT1 in tumor angiogenesis offer a new viewpoint on OS treatment.

Highlights

  • In children and adolescents, osteosarcoma (OS) is the most prevalent primary malignant tumor formed in the bone

  • Accumulating evidence indicates that metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) appears to serve as an oncogene in a variety of human malignancies, including OS, and angiogenesis is a critical process in the formation and progression of osteosarcoma

  • MALAT1 is overexpressed in OS, and silencing MALAT1 in the OS suppresses endothelial cell proliferation and migration

Read more

Summary

Introduction

Osteosarcoma (OS) is the most prevalent primary malignant tumor formed in the bone. Patients with osteosarcoma are usually treated with surgery and extensive adjuvant chemotherapy. Patients with OS who are treated with surgery alone have a survival rate of 15%–17%. In the last 30 years, survival rates for OS patients with metastasis or relapse have remained largely stable [1, 2]. Angiogenesis is a critical component in the formation and progression of OS, according to growing data [3]. Several regulators, including noncoding RNAs such as long noncoding RNAs (LncRNAs) and microRNAs, are involved in the OS-induced angiogenesis. LncRNAs are a type of noncoding RNA with a length of more than 200 nucleotides

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call